Food and Drug Administration Approves Soliris for Rare Pediatric Blood Disorder

被引：0

|

作者：

Nahlen, Dawn

机构：

来源：

NEWBORN AND INFANT NURSING REVIEWS | 2012年 / 12卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

引用

收藏

页码：E2 / E3

页数：2

相关论文

共 50 条

[21] FDA approves topical drug for pediatric onychomycosis
不详
NURSE PRACTITIONER, 2020, 45 (08): : 56 - 56
[22] Food & Drug Administration panel approves heart failure medication aimed at African-Americans
不详
PHARMACOGENOMICS, 2005, 6 (05) : 455 - 455
[23] US Food and Drug Administration Approves Gilead's Once-Daily HIV Pill
不详
CLINICAL INFECTIOUS DISEASES, 2011, 53 (09) : II - II
[24] Food and Drug Administration Approves First Generic Versions of the Antibiotic Levofloxacin to Treat Certain Infections
不详
CLINICAL INFECTIOUS DISEASES, 2011, 53 (09) : II - II
[25] Food and Drug Administration Approves Combination Vaccine that Protects Children Against 2 Bacterial Diseases
Nahlen, Dawn
NEWBORN AND INFANT NURSING REVIEWS, 2012, 12 (04) : E1 - E1
[26] NEW DRUG TREATS RARE BLOOD CLOTTING DISORDER
不详
AMERICAN JOURNAL OF NURSING, 2019, 119 (06) : 24 - 24
[27] Blood safety - The Food and Drug Administration's role
Gustafson, M
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1999, 123 (06) : 475 - 477
[28] Food and Drug Administration Requirements for Clinical Studies in Pediatric Patients
Tabor, Edward
THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (05) : 666 - 672
[29] Food and Drug Administration Requirements for Clinical Studies in Pediatric Patients
Edward Tabor
Therapeutic Innovation & Regulatory Science, 2015, 49 : 666 - 672
[30] US Food and Drug Administration approves pre-exposure prophylaxis use for adolescents: Next steps
Albritton, Tashuna
Eweka, Ivie
Fleuriscar, Jean
Fleuriscar, Jacqueline
Adeyemi-Jones, Adenike
Dillon, Brianna
PREVENTIVE MEDICINE, 2018, 116 : 222 - 222

← 1 2 3 4 5 →